Abstract
(Abstracted from Reprod Biomed Online 2019;39(3):439–445) Embryo cryopreservation and frozen embryo transfer (FET) in assisted reproductive technology currently accounts for up to one third of all children born in the United States using assisted reproductive technology. Embryo cryopreservation's increase in utilization is driven by advances in procedures associated with the technology as well as increased understanding of downstream effects associated with ovarian stimulation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
